Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Share of target population fully vaccinated.

Domain:

healthcare

Record type:

software
Creator:
RajMosJohTam
Host:avatar

The DHIS2 system enabled real-time tracking of vaccine distribution and administration to facilitate data-driven decisions. Experts from the Africa Centres for Disease Control and Prevention (Africa CDC) Monitoring and Evaluation (M&E) and Management Information System (MIS) teams, with support from the Health Information Systems Program South Africa (HISP-SA), developed the continental COVID-19 vaccination tracking system. Several variables related to COVID-19 vaccination were considered in developing the system. Three-hundred fifty users can access the system at different levels with specific roles and privileges. Four dashboards with high-level summary visualizations were developed for top leadership for decision-making, while pages with detailed programmatic results are available to other users depending on their level of access. Africa CDC staff at different levels with a role-based account can view and interact with the dashboards and make necessary decisions based on the COVID-19 vaccination data from program implementation areas on the continent. The Africa CDC vaccination program dashboard provided essential information for public health officials to monitor the continental COVID-19 vaccination efforts and guide timely decisions. As the impact of COVID-19 is not yet over, the continental tracking of COVID-19 vaccine uptake and dashboard visualizations are used to provide the context of continental COVID-19 vaccination coverage and multiple other metrics that may impact the continental COVID-19 vaccine uptake. The lessons learned during the development and implementation of a continental COVID-19 vaccination tracking and visualization dashboard may be applied across various other public health events of continental and global concern.

Visit

figshare.com

Tags

MedicineGeneticsBiotechnologyScience PolicyInfectious DiseasesBiological Sciences not elsewhere classifiedInformation Systems not elsewhere classifiedseveral variables relatedpublic health officialspublic health events+35

Licenses

CC BY 4.0

Similar

Target population estimate methods.Outbreak of Measles in vaccinated population in Southeastern NigeriaCharacterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan populationSerological Evidence of HBV Core Antibody Among Fully Vaccinated Infants in Cameroon: Implications for Perinatal Exposure and Vaccine ResponseTarget population estimates from 1999-2023.SEROPREVALENCE OF HEPATITIS B VIRUS INFECTION AND ASSOCIATED FACTORS AMONG HEPATITIS B FULLY VACCINATED CHILDREN IN DEBRE MARKOS TOWN, NORTH-WEST ETHIOPIA

Target population estimate methods.

This Excel file contains country-level data on annual live births from 1999 -2023 in Kenya derive

Outbreak of Measles in vaccinated population in Southeastern Nigeria

Background: Outbreaks of respiratory disease, febrile illness and rash occurred in two adjoining rur

Characterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population

Abstract Vaccination is a key control measure of COVID-19 by preventing severe effects of

Serological Evidence of HBV Core Antibody Among Fully Vaccinated Infants in Cameroon: Implications for Perinatal Exposure and Vaccine Response

Hepatitis B virus (HBV) remains highly endemic in sub-Saharan Africa, where perinatal and early chil

Target population estimates from 1999-2023.

Target population estimation for immunization coverage calculations from census data is ofte

SEROPREVALENCE OF HEPATITIS B VIRUS INFECTION AND ASSOCIATED FACTORS AMONG HEPATITIS B FULLY VACCINATED CHILDREN IN DEBRE MARKOS TOWN, NORTH-WEST ETHIOPIA

SEROPREVALENCE OF HEPATITIS B VIRUS INFECTION AND ASSOCIATED FACTORS AMONG HEPATITIS B FULLY VACCINA